Rankings
▼
Calendar
AMPH Q4 2020 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMPH
Amphastar Pharmaceuticals, Inc.
$894M
Q4 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$96M
+15.0% YoY
Gross Profit
$37M
38.4% margin
Operating Income
$3M
3.0% margin
Net Income
-$6M
-6.5% margin
EPS (Diluted)
$-0.13
QoQ Revenue Growth
+15.0%
Cash Flow
Operating Cash Flow
$17M
Free Cash Flow
$8M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$631M
Total Liabilities
$183M
Stockholders' Equity
$402M
Cash & Equivalents
$93M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$96M
$83M
+15.0%
Gross Profit
$37M
$33M
+10.3%
Operating Income
$3M
-$244,000
+1279.9%
Net Income
-$6M
-$1M
-511.4%
Revenue Segments
Active Pharmaceutical Ingredient Segment
$8M
100%
Geographic Segments
U
$91M
99%
C
$679,000
1%
← FY 2020
All Quarters
Q1 2021 →